HTSUY
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q4 | 0.16 | $311M | — |
| 2025 Q3 | 0.11 | $262M | — |
| 2025 Q2 | 0.11 | $275M | — |
| 2025 Q1 | 0.06 | $238M | — |
| 2025 Q4 | 0.18 | $291M | — |
| 2024 Q3 | 0.11 | $241M | — |
| 2024 Q2 | 14.69 | $258M | — |
| 2024 Q1 | 0.10 | $233M | — |